The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Soft Tissue Sarcomas
Open accessAbstract
Sarcomas are a heterogeneous group of rare tumors that arise predominantly from the embryonic mesoderm. They present most commonly as an asymptomatic mass originating in an extremity but can occur anywhere in the body, particularly the trunk, retroperitoneum, or the head and neck. Pretreatment radiologic imaging is critical for defining the local extent of a tumor, staging the disease, guiding biopsies, and aiding in diagnosis. Core-needle biopsy is the preferred biopsy technique for diagnosing soft tissue sarcomas. The American Joint Committee on Cancer (AJCC) staging system for soft tissue sarcomas is based on histologic grade, the tumor size and depth, and the presence of distant or nodal metastases. Despite improvements in local control rates with wide local resections and radiation therapy, metastasis and death remain a significant problem in 50% of patients who present with high-risk soft tissue sarcomas. The most common site of metastasis is the lungs, and metastasis generally occurs within two to three years after the completion of therapy. Progress in the molecular characteristics of these tumors should in the near future translate into molecularly based therapies that can be incorporated into standard treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Two Hundred Gastrointestinal Stromal Tumors: Recurrence Patterns and Prognostic Factors for Survival
DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S., Woodruff, J. M., & Brennan, M. F. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00008 · Cited by 2,554
Kindblom, L. G., Remotti, H. E., Aldenborg, F., & Meis‐Kindblom, J. M. (1998) · Europe PMC (PubMed Central) · Cited by 1,667
O'Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., Wunder, J., Kandel, R., Goddard, K., Sadura, A., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09292-9 · Cited by 1,598
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., & Ullrich, A. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02655.x · Cited by 1,574
Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., DeLaney, T., Glatstein, E., Steinberg, S. M., Merino, M. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.197 · Cited by 1,541
Zsebo, K. M., Williams, D. A., Geissler, E. N., Broudy, V. C., Martin, F. H., Atkins, H. L., Hsu, R.-Y., Birkett, N. C., Okino, K. H., Murdock, D. C., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90302-u · Cited by 1,388
ROSENBERG, S. A., TEPPER, J., GLATSTEIN, E., COSTA, J., BAKER, A., BRENNAM, M., DEMOSS, E. V., SEIPP, C., SINDELAR, W. F., SUGARBAKER, P., et al. (1982) · Annals of Surgery · doi:10.1097/00000658-198209000-00009 · Cited by 1,348
van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., di Paola, E. D., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06535-7 · Cited by 1,264
Pisters, P. W., Leung, D. H., Woodruff, J., Shi, W., & Brennan, M. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1679 · Cited by 1,220
(1997) · The Lancet · doi:10.1016/s0140-6736(97)08165-8 · Cited by 1,044
Pisters, P. W., Harrison, L. B., Leung, D. H., Woodruff, J. M., Casper, E. S., & Brennan, M. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.859 · Cited by 1,001
Identification of a ligand for the c-kit proto-oncogene
Williams, D. E., Eisenman, J., Baird, A., Rauch, C., Van Ness, K., March, C. J., Park, L. S., Martin, U., Mochizukl, D. Y., Boswell, H. S., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90297-r · Cited by 911
Guillou, L., Coindre, J. M., Bonichon, F., Nguyen, B. B., Terrier, P., Collin, F., Vilain, M. O., Mandard, A. M., Le Doussal, V, Leroux, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.350 · Cited by 864
Stem Cell Factor and Hematopoiesis
Broudy, V. C. (1997) · Blood · doi:10.1182/blood.v90.4.1345 · Cited by 858
Gastrointestinal stromal tumors: Recent advances in understanding of their biology
Miettinen, M., Sarlomo-Rikala, M., & Lasota, J. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90040-0 · Cited by 840
CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo‐Rikala, M., Kovatich, A. J., Barusevicius, A., & Miettinen, M. (1998) · PubMed · Cited by 770
Coindre, J.-M., Terrier, P., Guillou, L., Le Doussal, V., Collin, F., Ranch�re, D., Sastre, X., Vilain, M.-O., Bonichon, F., & N'Guyen Bui, B. (2001) · Cancer · doi:10.1002/1097-0142(20010515)91:10<1914::aid-cncr1214>3.0.co;2-3 · Cited by 740
Frustaci, S., Gherlinzoni, F., De Paoli, A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., Pignatti, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 712
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
Lux, M. L., Rubin, B. P., Biase, T. L., Chen, C.-J., Maclure, T., Demetri, G., Xiao, S., Singer, S., Fletcher, C. D. M., & Fletcher, J. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64946-2 · Cited by 642
Coindre, J. M., Terrier, P., Bui, N. B., Bonichon, F., Collin, F., Le Doussal, V, Mandard, A. M., Vilain, M. O., Jacquemier, J., Duplay, H., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.869 · Cited by 636
Van Glabbeke, M., van Oosterom, A. T., Oosterhuis, J. W., Mouridsen, H., Crowther, D., Somers, R., Verweij, J., Santoro, A., Buesa, J., & Tursz, T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.150 · Cited by 608
Fong, Y., Coit, D. G., Woodruff, J. M., & Brennan, M. F. (1993) · Annals of Surgery · doi:10.1097/00000658-199301000-00012 · Cited by 574
Effect of c-kit Mutation on Prognosis of Gastrointestinal Stromal Tumors
谷口, 正. (2001) · Cited by 438
Case-control study: Soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols
Hardell, L., & Sandström, A. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.125 · Cited by 413
Patterns of recurrence in patients with high-grade soft-tissue sarcomas.
Potter, D. A., Glenn, J., Kinsella, T., Glatstein, E., Lack, E. E., Restrepo, C., White, D. E., Seipp, C. A., Wesley, R., & Rosenberg, S. A. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.3.353 · Cited by 377
Eilber, F. C., Rosen, G., Eckardt, J., Forscher, C., Nelson, S. D., Selch, M., Dorey, F., & Eilber, F. R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3203 · Cited by 329
Comparison of Amputation With Limb-sparing Operations for Adult Soft Tissue Sarcoma of the Extremity
MILLIARD, W. C., HAJDU, S. I., CASPER, E. S., & BRENNAN, M. F. (1992) · Annals of Surgery · doi:10.1097/00000658-199203000-00012 · Cited by 281
Outcome and prognosis in retroperitoneal soft tissue sarcoma
Catton, C. N., O'Sullivan, B., Kotwall, C., Cummings, B., Hao, Y., & Fornasier, V. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90395-6 · Cited by 278
Analysis of Prognostic Factors
McGrath, P. C., Neifeld, J. P., Lawrence, W., Kay, S., Horsley, J. S., & Parker, G. A. (1987) · Annals of Surgery · doi:10.1097/00000658-198712000-00004 · Cited by 268
Radiation-Associated Sarcoma of Bone and Soft Tissue
Brady, M. S. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420120013002 · Cited by 258
Patel, S. R., Vadhan-Raj, S., Papadopolous, N., Plager, C., Burgess, M. A., Hays, C., & Benjamin, R. S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2378 · Cited by 257
The Role of Multimodality Therapy in Soft-tissue Sarcoma
BRENNAN, M. F., CASPER, E. S., HARRISON, L. B., SHIU, M. H., GAYNOR, J., & HAJDU, S. I. (1991) · Annals of Surgery · doi:10.1097/00000658-199109000-00015 · Cited by 245
Bramwell, V. H. C., Mouridsen, H. T., Santoro, A., Blackledge, G., Somers, R., Verwey, J., Dombernowsky, P., Onsrud, M., Thomas, D., Sylvester, R., et al. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90075-7 · Cited by 243
The epidemiology of soft tissue sarcoma.
Zahm, S. H., & Fraumeni, J. F. (1997) · PubMed · Cited by 232
Clinical trials with adriamycin
Middleman, E., Luce, J., & Frei, E. (1971) · Cancer · doi:10.1002/1097-0142(1971)28:4<844::aid-cncr2820280407>3.0.co;2-9 · Cited by 228
Gieschen, H. L., Spiro, I. J., Suit, H. D., Ott, M. J., Rattner, D. W., Ancukiewicz, M., & Willett, C. G. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01589-3 · Cited by 227
Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue Sarcoma
Singer, S., Corson, J. M., Gonin, R., Labow, B., & Eberlein, T. J. (1994) · Annals of Surgery · doi:10.1097/00000658-199402000-00008 · Cited by 206
Jones, J. J., Catton, C. N., O’Sullivan, B., Couture, J., Heisler, R. L., Kandel, R. A., & Swallow, C. J. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02573869 · Cited by 206
Stinson, S. F., Delaney, T. F., Greenberg, J., Yang, J. C., Lampert, M. H., Hicks, J. E., Venzon, D., White, D. E., Rosenberg, S. A., & Glatstein, E. J. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90324-w · Cited by 203
Wound-Healing Complications after Soft-Tissue Sarcoma Surgery
Peat, B. G., Bell, R. S., Davis, A., OʼSullivan, B., Mahoney, J., Manktelow, R. T., Bowen, V., Catton, C., Fornasier, V. L., & Langer, F. (1994) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-199404001-00012 · Cited by 194
Petersen, I. A., Haddock, M. G., Donohue, J. H., Nagorney, D. M., Grill, J. P., Sargent, D. J., & Gunderson, L. L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02595-0 · Cited by 183
Soft Tissue Sarcoma and Exposure to Phenoxyherbicides and Chlorophenols in New Zealand 2
Smith, A. H., Pearce, N. E., Fisher, D. O., Giles, H. J., Teague, C. A., & Howard, J. (1984) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/73.5.1111 · Cited by 169
Presant, C. A., Russell, W. O., Alexander, R. W., & Fu, Y. S. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.11.1658 · Cited by 162
Demas, B., Heelan, R. T., Lane, J. M., Marcove, R. C., Hajdu, S., & Brennan, M. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.3.615 · Cited by 147
Wound healing after preoperative radiation for sarcoma of soft tissues.
Bujko, K., Suit, H. D., Springfield, D. S., & Convery, K. M. (1993) · PubMed · Cited by 137
Alvegård, T. A., & Berg, N. O. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1845 · Cited by 113
Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.
Latres, E., Drobnjak, M., Pollack, D. M., Oliva, M. R., Ramos, M., Karpeh, M. S., Woodruff, J. M., & Cordon‐Cardo, C. (1994) · PubMed · Cited by 76
Effective follow-up strategies in soft tissue sarcoma
Whooley, B. P., Mooney, M., Gibbs, J. F., & Kraybill, W. G. (1999) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199907/08)17:1<83::aid-ssu11>3.0.co;2-w · Cited by 65
Palumbo, R., Palmeri, S., Antimi, M., Gatti, C., Raffo, P., Villani, G. M., & Toma, S. (1997) · Annals of Oncology · doi:10.1023/a:1008279426654 · Cited by 64
Imaging of Soft Tissue Sarcomas
Heslin, M. J., & Smith, J. K. (1999) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30227-8 · Cited by 47
New diagnostic modalities in soft tissue sarcoma
Singer, S. (1999) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199907/08)17:1<23::aid-ssu4>3.0.co;2-r · Cited by 30
Mutant p53 expression: a marker of diminished survival in well-differentiated soft tissue sarcoma.
Hieken, T. J., & Gupta, T. K. D. (1996) · PubMed · Cited by 27
Cited by
Childhood and adolescent cancer statistics, 2014
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21219 · Cited by 2,412
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., DeLaney, T., Glatstein, E., Steinberg, S. M., Merino, M. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.197 · Cited by 1,541
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality
Ling, C. C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S., & Koutcher, J. A. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00467-3 · Cited by 926
Metadata
- Authors
- Cormier, J. N., & Pollock, R. E.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2004-03-01
- Volume
- 54
- Issue
- 2
- Pages
- 94-109
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2020617188
- Cited by
- 835
- References
- 54
- FWCI
- 29.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.